CF Industries Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CF Industries Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.08B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $5.94B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $6.63B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $11.19B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $6.54B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.12B | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $1.05B | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $1.04B | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $1.50B | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $1.00B | Feb 24, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $1.12B | Feb 25, 2016 |
| FY2015 | Sep 30, 2015 | $927.40M | Feb 25, 2016 |
| FY2015 | Jun 30, 2015 | $1.31B | Feb 25, 2016 |
| FY2015 | Mar 31, 2015 | $953.60M | Feb 25, 2016 |
| FY2015 | Dec 31, 2014 | $1.22B | Feb 25, 2016 |
| FY2015 | Sep 30, 2014 | $921.40M | Feb 25, 2016 |
| FY2015 | Jun 30, 2014 | $1.47B | Feb 25, 2016 |
| FY2015 | Mar 31, 2014 | $1.13B | Feb 25, 2016 |
| FY2014 | Dec 31, 2013 | $1.33B | Feb 26, 2015 |
| FY2014 | Sep 30, 2013 | $1.10B | Feb 26, 2015 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.72B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.06B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.55B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $5.86B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.39B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $801.00M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $227.00M | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | $228.00M | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | $499.00M | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | $220.00M | Feb 24, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $1.54B | Feb 27, 2012 |
| FY2010 | Dec 31, 2010 | $349.20M | Feb 25, 2011 |
| FY2009 | Dec 31, 2009 | $365.60M | Feb 25, 2010 |
| FY2009 | Dec 31, 2008 | $684.60M | Feb 25, 2010 |
| FY2009 | Dec 31, 2007 | $372.70M | Feb 25, 2010 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.30B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.75B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.23B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $5.40B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.73B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $623.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.00B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $766.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $234.00M | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $1.19B | Feb 25, 2016 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $364.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $320.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $289.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $290.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $223.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $206.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $239.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $214.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $191.00M | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $169.80M | Feb 25, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.75B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.27B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $2.76B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $3.86B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.87B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.23B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.51B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.50B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $1.63B | Feb 24, 2020 |
| FY2010 | Dec 31, 2010 | $1.19B | Feb 25, 2011 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $950.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $518.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $499.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $453.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $514.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $309.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $404.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $422.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $473.00M | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $2.47B | Feb 25, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.09B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $13.47B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $14.38B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $13.31B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $12.38B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $12.02B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $12.17B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $12.66B | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $12.74B | Feb 25, 2016 |
| FY2015 | Dec 31, 2014 | $11.25B | Feb 25, 2016 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.84B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.99B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $5.72B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $5.05B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.21B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.92B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.90B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.96B | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $4.04B | Feb 25, 2016 |
| FY2015 | Dec 31, 2014 | $4.21B | Feb 25, 2016 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.49B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.49B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2.50B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $2.09B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.09B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.37B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.37B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.35B | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $2.39B | Feb 25, 2016 |
| FY2015 | Dec 31, 2014 | $2.09B | Feb 25, 2016 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.87B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.01B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $4.54B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $3.87B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.09B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.93B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.96B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.46B | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $3.06B | Feb 25, 2016 |
| FY2015 | Dec 31, 2014 | $3.18B | Feb 25, 2016 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $287.00M | Feb 24, 2020 |
| FY2019 | Dec 31, 2018 | $682.00M | Feb 24, 2020 |
| FY2019 | Dec 31, 2017 | $835.00M | Feb 24, 2020 |
| FY2019 | Dec 31, 2016 | $1.17B | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $286.00M | Feb 25, 2016 |
| FY2015 | Dec 31, 2014 | $2.00B | Feb 25, 2016 |
| FY2015 | Dec 31, 2013 | $1.71B | Feb 25, 2016 |
| FY2015 | Dec 31, 2012 | $2.27B | Feb 25, 2016 |
| FY2014 | Dec 31, 2011 | $1.21B | Feb 26, 2015 |
| FY2013 | Dec 31, 2010 | $797.70M | Feb 27, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.22B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.97B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $2.97B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $2.97B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.47B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.96B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $3.96B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $4.70B | Feb 24, 2020 |
| FY2014 | Dec 31, 2014 | $4.59B | Feb 26, 2015 |
| FY2014 | Dec 31, 2013 | $3.10B | Feb 26, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 16 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 24, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 16 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 24, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 24, 2020 |
| FY2019 | Jun 30, 2019 | 1 | Feb 24, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 24, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 153.55M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 169.88M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 188.19M | Feb 25, 2026 |
| FY2025 | Dec 31, 2022 | 195.60M | Feb 25, 2026 |
| FY2024 | Dec 31, 2021 | 207.58M | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | 213.95M | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | 216.02M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | 222.82M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | 233.29M | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | 233.11M | Feb 24, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $326.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $364.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $311.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $306.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $260.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $258.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $265.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $280.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $280.00M | Feb 24, 2020 |
| FY2015 | Dec 31, 2015 | $282.30M | Feb 25, 2016 |